GaoWZhangQGeHGuoYZhouZ. Angiology efficacy and safety of triple antiplatelet [published online January 27, 2013]. Angiology. 2013.
2.
AlHabibKFHersiAAlsheikh-AliAA. Prevalence, predictors, and outcomes of conservative medical management in non-ST-segment elevation acute coronary syndromes in Gulf RACE-2. Angiology. 2012;63(2):109–118.
3.
De AlbuquerqueRMVirgini-MagalhãesCELencastre SicuroFBottinoDABouskelaE. Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication. Angiology. 2008;59(5):549–558.
4.
TsuchikaneEFukuharaAKobayashiT. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Circulation. 1999;100(1):21–26.
5.
DouglasJSHolmesDRKereiakesDJ. Coronary stent restenosis in patients treated with cilostazol. Circulation. 2005;112(18):2826–2832.
6.
LeeS-WParkS-WKimY-H. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial. J Am Coll Cardiol. 2011;57(11):1264–1270.
7.
GagliaMATorgusonRPakalaR. Relation of body mass index to on-treatment (clopidogrel + aspirin) platelet reactivity. Am J Cardiol. 2011;108(6):766–771.
8.
CinVGPekdemirHAkkusMNCamsariADovenOYenihanS. Cutting balloon angioplasty for the treatment of in-stent restenosis in diabetics: a matched comparison of 6 months’ outcome with conventional balloon angioplasty. Angiology. 2006;57(4):445–452.
9.
HikitaHKurodaSKawaguchiN. Differential characteristics of inflammatory responses to stent implantation between de novo and intrastent restenosis lesion in patients with stable angina. Angiology. 2012;63(2):92–95.
10.
AthyrosVGKakafikaAIKaragiannisAMikhailidisDP. Do we need to consider inflammatory markers when we treat atherosclerotic disease?Atherosclerosis. 2008;200(1):1–12.
11.
GurmericSIsguderGGCarlierSUnalG. A new 3-D automated computational method to evaluate in-stent neointimal hyperplasia in in-vivo intravascular optical coherence tomography pullbacks. Med Image Comput Comput Assist Interv. 2009;12(Pt 2):776–785.
12.
YoshitomiYKojimaSYanoM. Peristent tissue proliferation of multilink stents is dependent on preprocedural plaque area: a serial intravascular ultrasound analysis. Angiology. 2002;53(3):303–311.
13.
MaekawaYKawamuraAYuasaS. Outcomes of intravascular ultrasound-guided percutaneous coronary intervention with drug-eluting stents versus bare metal stents for acute coronary syndrome in octogenarians. Angiology. 2011;62(8):620–624.
14.
AltinTBerkalpBOzdolC. Angiographic restenosis in ephesos coronary stents: experience from a large medical center in Ankara, Turkey. Angiology.2008;59(1):47–51.
